Lansoprazole Delayed-Release Capsules USP
CGMP Deviations
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,535 recalls, newest first.
CGMP Deviations
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Failed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study.
Failed Dissolution Specifications
Lack of Assurance of Sterility: leaking bags
Lack of assurance of sterility: bags have the potential to leak..
Subpotent Drug
cGMP Diviations
CGMP Deviations
The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.
Failed Dissolution Specifications
Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.
Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Failed Stability Specifications
Failed Stability Specifications
Lack of Assurance of Sterility: Firm did not perform process validation.
Lack of Assurance of Sterility: Firm did not perform process validation.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility